Related Experiment Video
Updated: Aug 7, 2026
12:55
Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Apoptosis-regulating proteins as targets for drug discovery
1The Burnham Institute, La Jolla, CA 92037, USA. jreed@burnham.org
Trends in Molecular Medicine
|June 27, 2001
Summary
Dysregulation of programmed cell death (apoptosis) is implicated in numerous diseases. Understanding apoptosis regulation and caspase structures offers new therapeutic strategies for various illnesses.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Apoptosis, or programmed cell death, is crucial for health and disease.
- Defects in apoptosis contribute to diseases like cancer, neurodegeneration, and autoimmune disorders.
- Caspases are key proteases that execute the apoptotic process.
Purpose of the Study:
- To explore the role of apoptosis regulation in disease.
- To investigate the molecular mechanisms and protein structures involved in apoptosis.
- To identify new therapeutic strategies targeting apoptosis.
Main Methods:
- Review of current literature on apoptosis regulation.
- Analysis of molecular details of apoptosis.
- Examination of three-dimensional protein structures of apoptosis machinery.
Main Results:
- Apoptosis defects are linked to cell loss and failure to eliminate harmful cells.
- Caspase regulators influence cell death and survival decisions.
- Structural knowledge of apoptosis proteins reveals therapeutic targets.
Conclusions:
- Understanding apoptosis regulation is vital for treating diverse diseases.
- Targeting caspases and their regulators offers potential for novel drug development.
- Further research into apoptosis pathways can lead to more effective treatments.
Related Concept Videos
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...